ABCD1 and X-linked adrenoleukodystrophy: Moreover, DMF treatment of an Abcd1/2 double KO mouse model of X-ALD reversed signs of astrocytosis, microgliosis, and axonal and myelin degeneration, and enhanced locomotor function.